Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate Combined With Dutasteride in Castrate-Resistant Prostate Cancer
NCT01393730Phase 2Completed
- Start
- Sep 2011
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dutasteride in prostate cancer (PCa). Primary endpoint: Number of Participants With Androgen Receptor (AR) Related Mutations up to 48 months. Started Sep 2011; status: completed.
02
Drugs
dutasteride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01393730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393730.